{
    "clinical_study": {
        "@rank": "16500", 
        "arm_group": {
            "arm_group_label": "Induction of flow limitation", 
            "arm_group_type": "Experimental", 
            "description": "Flow limitation will be induced by sustained reductions in continuous positive airway pressure during sleep"
        }, 
        "brief_summary": {
            "textblock": "In obstructive sleep apnea (OSA), the upper airway recurrently closes during sleep. The\n      mechanisms that lead to airway closure are not completely understood. Some studies have\n      shown that there is progressive narrowing of the pharyngeal airway across breaths during\n      expiration (Progressive Expiratory Narrowing, PEN) preceding an obstructive apnea. The cause\n      of PEN is unknown.  The investigators will test if lung volumes and low respiratory drive\n      play a role in PEN."
        }, 
        "brief_title": "Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "The mechanisms that lead to airway closure in OSA are not completely understood. Some\n      studies have shown that there is progressive narrowing of the pharyngeal airway across\n      breaths during expiration (Progressive Expiratory Narrowing, PEN) preceding an obstructive\n      apnea.\n\n      The investigators will test if lung volumes and low respiratory drive play a role in PEN. To\n      this end, the investigators will visualize the pharynx of sleep apnea patients during sleep\n      using a thin endoscope during sleep while simultaneously measuring lung volumes,\n      genioglossus electromyogram, and pharyngeal pressure during flow-limited breaths. Flow\n      limitation will be induced by sustained reductions of continuous positive airway pressure\n      (CPAP)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal subjects or patients with OSA\n\n        Exclusion Criteria:\n\n          -  Any unstable cardiac condition (other than well controlled hypertension) or pulmonary\n             problems.\n\n          -  Any medication known to influence breathing, sleep/arousal or muscle physiology\n\n          -  Concurrent sleep disorders (insomnia, narcolepsy, central sleep apnea or parasomnia)\n\n          -  Claustrophobia\n\n          -  Inability to sleep supine\n\n          -  Allergy to lidocaine or oxymetazoline hydroclhoride\n\n          -  For women: Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01738009", 
            "org_study_id": "2012P000957B", 
            "secondary_id": "1R01HL102321-01A1"
        }, 
        "intervention": {
            "arm_group_label": "Induction of flow limitation", 
            "intervention_name": "Induction of flow limitation", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sleep Apnea", 
            "Pathophysiology"
        ], 
        "lastchanged_date": "September 25, 2013", 
        "location": {
            "contact": {
                "email": "pgenta@partners.org", 
                "last_name": "Pedro R Genta, MD", 
                "phone": "617-732-6541"
            }, 
            "contact_backup": {
                "email": "lhess1@partners.org", 
                "last_name": "Lauren B Hess, BS", 
                "phone": "(617) 732-8976"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Brigham and Women's Hospital"
            }, 
            "investigator": {
                "last_name": "Pedro R Genta, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B", 
        "overall_contact": {
            "email": "pgenta@partners.org", 
            "last_name": "Pedro R Genta, MD", 
            "phone": "(617) 732-6541"
        }, 
        "overall_contact_backup": {
            "email": "lhess1@partners.org", 
            "last_name": "Lauren B Hess, BS", 
            "phone": "(617) 732-8976"
        }, 
        "overall_official": {
            "affiliation": "Brigham and Women's Hospital", 
            "last_name": "David A Wellman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measured peak inspiratory flow will be compared to predicted peak inspiratory flow during flow restricted breaths.\nThe time frame for the outcome will be the duration of induced flow limitation (3 minutes each) . Flow limitation will be induced several times during the night. Flow limited breaths will be averaged.", 
            "measure": "Difference in peak inspiratory flow", 
            "safety_issue": "No", 
            "time_frame": "3 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01738009"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "David Andrew Wellman", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}